Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Dynamics and Amersham Sign Dupont As Microarray Partner


SUNNYVALE, Calif.--Molecular Dynamics here, in partnership with Amersham International, has entered an agreement with Dupont Agricultural Products to continue development of microarray technologies that speed genetic research. Under terms of the deal, Dupont will provide funding and share its expertise, in exchange for early access to the technologies, which Dupont will use to study gene expression levels in agricultural seed and plant species and to develop products that improve the health and disease-resistance of agricultural plants.

While Molecular Dynamics and Amersham have six other collaborators involved with their microarray technology, Dupont is the first in the agricultural area, they noted.

In other news, Molecular Dynamics has released third quarter results that show gains in revenues, net income, and net per share for both the three- and nine-month periods ended September 30, compared to the same periods in 1996.

For the quarter, the company posted revenues of $14.37 million, net income of $1.38 million, and earning of 12 cents per share. Year-ago figures were $12.91 million, $1.07 million, and 10 cents a share.

During the past nine months, Molecular Dynamics had revenues of $41.25 million, net income of $3.97 million, and earnings of 35 cents per share. Comparable 1996 results were $35.95 million, $1.99 million, and 19 cents a share. Molecular Dynamics makes systems for genetic research. The company recently announced a new high-throughput DNA sequencing and mapping device that will become commercially available in 1998.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.